Atypical antidepressants
26,040views
00:00 / 00:00
Flashcards
Atypical antidepressants
0 of 12 complete
Questions
USMLE® Step 1 style questions USMLE
0 of 6 complete
USMLE® Step 2 style questions USMLE
0 of 12 complete
Memory Anchors and Partner Content
External References
First Aid
2024
2023
2022
2021
Bupropion p. 594
major depressive disorder p. 578
mechanism p. 592
nicotine withdrawal p. 589
seizures with p. 250
Dopamine p. 241, 332
bupropion effect p. 594
Headache p. 532
bupropion toxicity p. 594
Norepinephrine (NE)
bupropion effect on p. 594
Seizures p. 531
bupropion p. 594
Smoking
bupropion for cessation p. 594
External Links
Transcript
Content Reviewers
Atypical antidepressants are mainly used to treat major depressive disorder. This disorder causes a persistent feeling of sadness and loss of interest in everyday activities. Even though the exact cause of depression is still unknown, there's some evidence that suggests it’s related to low levels of neurotransmitters like serotonin, norepinephrine, and dopamine. Typical antidepressants like selective serotonin reuptake inhibitors or tricyclic antidepressants work by increasing the levels of serotonin and norepinephrine, while atypical antidepressants often have multiple mechanisms of action.
All right, now within the brain, there are many different types of neurons, but we’re going to focus only on three: serotonergic neurons, which produce serotonin; noradrenergic neurons, which produce norepinephrine; and dopaminergic neurons, which produce dopamine. Each of these neurons synthesizes and stores their neurotransmitters in small vesicles. So, when an action potential reaches the presynaptic membrane, these vesicles fuse with the membrane, releasing neurotransmitters into the synaptic cleft. Once released, serotonin (or 5-HT) binds to 5-HT2 receptors on the postsynaptic membrane, thereby increasing neural stimulation, and regulating mood, feeding, and reproductive behavior. On the other hand, norepinephrine binds to norepinephrine receptors on the postsynaptic membrane, boosting alertness. And finally, dopamine binds to dopamine receptors, thereby stimulating cognitive functions, motivation, and awakeness.
As long as there’s a high enough concentration of neurotransmitters in the synaptic cleft, the postsynaptic neurons will continue to fire. Now, serotonergic neurons on their presynaptic membrane have serotonin transporters (or SERT); noradrenergic neurons have norepinephrine transporters (or NET); while dopaminergic neurons have dopamine transporters (or DAT). These membrane proteins transport neurotransmitters from the synaptic cleft back into presynaptic neurons. This leads to a decreased neurotransmitter concentration within the synaptic cleft, causing the postsynaptic neurons to stop firing. Noradrenergic and serotonergic neurons are also rich in alpha 2 receptors. When stimulated, alpha 2 receptors inhibit the activity of the presynaptic neurons and decrease the release of norepinephrine or serotonin.
Summary
Atypical antidepressants are a class of antidepressant drugs that are distinguished from traditional, older antidepressant medications by their unique mechanism of action. They are generally reserved for cases that do not respond to other antidepressants. The atypical antidepressants include drugs like agomelatine, mirtazapine, and bupropion.
Atypical antidepressants are generally better tolerated than older drugs, and they are often just as effective. They are not without their side effects, however. The most common side effects of atypical antidepressants include nausea, headaches, anxiety, insomnia, and sexual dysfunction.
Sources
- "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
- "Rang and Dale's Pharmacology" Elsevier (2019)
- "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
- "Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice" Rivista di Psichiatria (2019)
- "A review of trazodone use in psychiatric and medical conditions" Postgraduate Medicine (2016)
- "Bupropion Hydrochloride" Profiles of Drug Substances, Excipients and Related Methodology (2016)
- "Vortioxetine for depression in adults" Cochrane Database of Systematic Reviews (2017)
- "Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis" Journal of Affective Disorders (2018)